Department of Health Research, Health Education and Research Organization (HERO), Buea, 154, Cameroon.
Ecole de Santé Publique, Université Libre de Bruxelles, Brussel, 1070, Belgium.
Int Health. 2023 Nov 3;15(6):702-714. doi: 10.1093/inthealth/ihad013.
This study investigated the determinants of coronavirus disease 2019 (COVID-19) vaccine hesitancy among healthcare workers (HCWs) in Cameroon and Nigeria.
This analytic cross-sectional study was conducted from May to June 2021, including consenting HCWs aged ≥18 y identified using snowball sampling. Vaccine hesitancy was defined as indecisiveness or unwillingness to receive the COVID-19 vaccine. Multilevel logistic regression yielded adjusted ORs (aORs) for vaccine hesitancy.
We included a total of 598 (about 60% women) participants. Little or no trust in the approved COVID-19 vaccines (aOR=2.28, 95% CI 1.24 to 4.20), lower perception of the importance of the vaccine on their personal health (5.26, 2.38 to 11.6), greater concerns about vaccine-related adverse effects (3.45, 1.83 to 6.47) and uncertainty about colleagues' acceptability of the vaccine (2.98, 1.62 to 5.48) were associated with higher odds of vaccine hesitancy. In addition, participants with chronic disease (aOR=0.34, 95% CI 0.12 to 0.97) and higher levels of concerns about getting COVID-19 (0.40, 0.18 to 0.87) were less likely to be hesitant to receive the COVID-19 vaccine.
COVID-19 vaccine hesitancy among HCWs in this study was high and broadly determined by the perceived risk of COVID-19 and COVID-19 vaccines on personal health, mistrust in COVID-19 vaccines and uncertainty about colleagues' vaccine acceptability.
本研究调查了喀麦隆和尼日利亚医护人员(HCWs)对 2019 年冠状病毒病(COVID-19)疫苗犹豫不决的决定因素。
这项分析性横断面研究于 2021 年 5 月至 6 月进行,包括使用雪球抽样确定的同意参与的年龄≥18 岁的 HCWs。疫苗犹豫定义为犹豫不决或不愿意接种 COVID-19 疫苗。多水平逻辑回归得出疫苗犹豫的调整优势比(aOR)。
我们共纳入了 598 名(约 60%为女性)参与者。对批准的 COVID-19 疫苗几乎没有或完全不信任(aOR=2.28,95%CI 1.24 至 4.20)、对疫苗对个人健康重要性的认知较低(5.26,2.38 至 11.6)、对疫苗相关不良反应的担忧更大(3.45,1.83 至 6.47)以及对同事对疫苗接受程度的不确定性(2.98,1.62 至 5.48)与更高的疫苗犹豫几率相关。此外,患有慢性病的参与者(aOR=0.34,95%CI 0.12 至 0.97)和对感染 COVID-19 的担忧程度较高(0.40,0.18 至 0.87)的参与者不太可能对接种 COVID-19 疫苗犹豫不决。
本研究中 HCWs 对 COVID-19 疫苗犹豫不决的程度较高,广泛取决于个人健康方面对 COVID-19 和 COVID-19 疫苗的感知风险、对 COVID-19 疫苗的不信任以及对同事疫苗接受程度的不确定性。